Tim Sobolevsky (T Sobolevsky)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Simultaneous Determination

Liquid Chromatography

Mass Spectrometry

Top Venues

Drug testing and analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Tim Sobolevsky, Yulia Kucherova, Brian Ahrens
Detection of selective androgen receptor modulator YK-11 in a doping control sample. Drug testing and analysis (2023)
Tim Sobolevsky, Katja Walpurgis, Christian Görgens, Matthew N Fedoruk, Laura Lewis, Brian Ahrens, Mario Thevis
Detection of capromorelin in urine following oral and dermal routes of administration. Drug testing and analysis (2023)
Tim Sobolevsky, Thomas Piper, Brian Ahrens, Mario Thevis
AICAr to SAICAr ratio can serve as additional marker of AICAr use. Drug testing and analysis (2022)
Sven Guddat, Christian Görgens, Tim Sobolevsky, Mario Thevis
Meldonium residues in milk: A possible scenario for inadvertent doping in sports? Drug testing and analysis (2021)
Tim Sobolevsky, Brian Ahrens
Biotin as a masking agent in chorionic gonadotropin assays utilizing biotinylated antibodies. Drug testing and analysis (2021)
Tim Sobolevsky, Brian Ahrens
Measurement of urinary cobalt as its complex with 2-(5-chloro-2-pyridylazo)-5-diethylaminophenol by liquid chromatography-tandem mass spectrometry for the purpose of anti-doping control. Drug testing and analysis 13 (6) (2021)
Tim Sobolevsky, Brian Ahrens
High-throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fraction. Drug testing and analysis 13 (2) (2020)
Tim Sobolevsky, Brian Ahrens
Urinary concentrations of AICAR and mannitol in athlete population. Drug testing and analysis 11 (3) (2019)
Tim Sobolevsky, Yulia Kucherova, Brian Ahrens
Isotopically labeled boldenone as a better marker of derivatization efficiency for improved quality control in anti-doping analysis. Drug testing and analysis 11 (2) (2018)
Tim Sobolevsky, Y Kucherova, B Ahrens
Identification of oxymorphone as decomposition product of the permitted drug methylnaltrexone. Drug testing and analysis 10 (5) (2018)